Pulse Biosciences, Inc. Increase (Decrease) in Deferred Revenue
Pulse Biosciences, Inc. (PLSE) reported Increase (Decrease) in Deferred Revenue of $22.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2022-11-10
- Pulse Biosciences, Inc. increase (decrease) in deferred revenue for the quarter ending 2022-09-30 was $6.00K.
- Pulse Biosciences, Inc. increase (decrease) in deferred revenue for the quarter ending 2021-12-31 was $9.00K.
- Pulse Biosciences, Inc. increase (decrease) in deferred revenue for the quarter ending 2015-12-31 was $1.00K.
- Pulse Biosciences, Inc. increase (decrease) in deferred revenue for the quarter ending 2015-09-30 was -$1.00K.
- Pulse Biosciences, Inc. increase (decrease) in deferred revenue for fiscal 2021 was $16.00K.
- Pulse Biosciences, Inc. increase (decrease) in deferred revenue for fiscal 2015 was -$39.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 7 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $22.00K 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $16.00K 10-Q · filed 2022-08-10 | ||||
| 2021-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $16.00K 10-K · filed 2022-03-31 | |||
| 2021-09-30 | $7.00K 10-Q · filed 2022-11-10 | ||||
| 2015-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $0.00 derived: sum of 2 quarters · filed 2018-03-16 | $0.00 derived: sum of 3 quarters · filed 2018-03-16 | -$39.00K 10-K · filed 2018-03-16 | |
| 2015-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$1.00K derived: sum of 2 quarters · filed 2016-11-14 | -$40.00K 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$39.00K 10-Q · filed 2016-08-10 | |||
| 2015-03-31 | -$39.00K 10-Q · filed 2016-06-27 | ||||
| 2014-12-31 | -$17.00K 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |